Good progress on dry-AMD treatment trials

Human trials of OpRegen from Israeli biotech Cell Cure (see here) at Hadassah Medical Center are proceeding well.  This unique stem cell therapy aims to stop progression of the dry form of Age-Related Macular Degeneration (AMD) that leads to blindness.

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *